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2014-15 Influenza Vaccine Recommendations 
The recommendation for children age 6 months through 8 years old is to receive two doses of flu vaccine this 
season separated by at least 4 weeks.   However, if any of the following apply, children in this age group will 
need just one dose of flu vaccine: 
o At least one dose of 2013-14 flu vaccine was received; 
o At least two doses of seasonal flu vaccine were received on or after July 1, 2010; 
o At least one dose of seasonal flu vaccine was received prior to July 1, 2010 and at least one dose 
was received after July 1, 2010; or 
o At least 2 doses of seasonal flu vaccine were received prior to July 1, 2010 and at least 1 dose of 
monovalent 2009 (H1N1) vaccine was received. 
 
Live Attenuated Influenza Vaccine (LAIV) is preferred for children 2 through 8 years of age, if no 
contraindication exists.  If LAIV is not available, Inactivated Influenza Vaccine (IIV) should be given; vaccination 
should not be delayed in an attempt to obtain LAIV.  
 
An allergy to eggs should not prevent someone from getting vaccinated against influenza.  Recombinant 
Influenza Vaccine (Flublok) should be administered to egg-allergic individuals 18 to 49 years of age. If egg-
allergic individuals are younger than 18 years old, or if Flublok is unavailable, IIV should be administered by a 
physician with experience in the recognition and management of severe allergic conditions.  Full 
recommendations can be found at www.cdc.gov/mmwr/preview/mmwrhtml/mm6332a3.htm/. 
 
For questions regarding the influenza vaccine, call Kelli Smith or Bethany Kintigh at 1-800-831-6293 ext. 
2 & 7, respectively.  For questions regarding VFC influenza vaccine availability, call Tina Patterson at 1- 
800-831-6293 ext. 4.   
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Influenza Vaccine Dosing Algorithm for Children Aged 6 Months through 8 Years 
Advisory Committee on Immunization Practices, United States, 
2014–15 Influenza Season 
 
 
• Doses should be administered at least 4 weeks apart.  
• For simplicity, this algorithm takes into consideration only doses of seasonal influenza 
vaccine received since July 1, 2010.  
As an alternative approach in settings where vaccination history from before July 1, 2010, is available, if a child 
aged 6 months through 8 years is known to have received at least 2 seasonal influenza vaccines during any 
previous season, and at least 1 dose of a 2009(H1N1)-containing vaccine (i.e., either 2010–11, 2011–12, 2012-
13 or 2013-14 seasonal vaccine or the monovalent 2009[H1N1] vaccine), then the child needs only 1 dose of  
2014–15 seasonal influenza vaccine.   
 
Using this approach, children aged 6 months through 8 years need only 1 dose of seasonal influenza vaccine in 
2014–15 if they have received any of the following:  
1) 1 or more doses of seasonal influenza vaccine in 2013-14; 
2) 2 or more doses of seasonal influenza vaccine since July 1, 2010;  
3) 2 or more doses of seasonal influenza vaccine before July 1, 2010, and 1 or more doses of monovalent 
2009(H1N1) vaccine; or  
4) 1 or more doses of seasonal influenza vaccine before July 1, 2010, and 1 or more doses of seasonal 
influenza vaccine since July 1, 2010.  
 
Adapted from the Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the 
Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season.  The full 
article is available here. 
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Recommendations Regarding Influenza Vaccination for Persons Who Report 
Allergy to Eggs Advisory Committee on Immunization Practices, United States,  
2014–15 Influenza Season 
 
 
Abbreviations: RIV3 = recombinant influenza vaccine, trivalent; IIV = inactivated influenza vaccine 
• Persons with egg allergy might tolerate egg in baked products (e.g., bread or cake).  Tolerance to 
egg-containing foods does not exclude the possibility of egg allergy. 
† For individuals who have no known history of exposure to egg, but who are suspected of being egg-
allergic on the basis of previously performed allergy testing, consultation with a physician with 
expertise in the management of allergic conditions should be obtained prior to vaccination.  
Alternatively, RIV3 may be administered if the recipient is aged 18 through 49 years. 
 
Adapted from Prevention and Control of Seasonal Influenza with Vaccines: Recommendations 
of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 
Influenza Season.  The full article is available here. 
  
Influenza Vaccine Information, by Age Group - United States, 2014–15 Influenza Season 
 
Vaccine Type Trade Name Manufacturer Presentation Mercury/Ovalbumin Content (µg per 0.5 mL dose) Age Group Route 
Inactivated 
Influenza Vaccine,   
Trivalent (IIV3), 
Standard Dose 
Afluria® bioCSL  0.5 mL single dose 
prefilled syringe 
0.0/< 1 ≥9 yrs. IM 
5.0 mL multidose vial 24.5/<1 
Fluarix® GlaxoSmithKline 0.5 mL single dose 
prefilled syringe 
0.0/≤ 0.05 ≥3 yrs. IM 
Flucelvax® Novartis Vaccines 0.5 mL single dose 
prefilled syringe 
0.0/Estimated at < 50 
femtograms* total egg protein 
≥18 yrs. IM 
FluLaval® ID Biomedical 
Corporation of 
Quebec (distributed 
by GlaxoSmithKline) 
0.5 mL single dose 
prefilled syringe 
0.0/≤0.3 ≥3 yrs. IM 
5.0 mL multidose vial <25.0/≤ 0.3 
Fluvirin® Novartis Vaccines 0.5 mL single dose 
prefilled syringe 
≤1/≤ 1 ≥4 yrs. IM 
5.0 mL multidose vial  25.0/≤ 1 
Fluzone® Sanofi Pasteur 0.5 mL single dose 
prefilled syringe 
0.0/** ≥36 mos. IM 
5.0 mL multidose vial 25.0/** ≥6 mos. 
Fluzone® 
Intradermal 
Sanofi Pasteur 0.1 mL prefilled 
microinjection system 
0.0 (per 0.1 mL)/** 18 – 64 yrs. ID 
Inactivated 
Influenza Vaccine, 
Trivalent (IIV3), 
High Dose 
Fluzone® High-
Dose 
Sanofi Pasteur 0.5 mL single dose 
prefilled syringe 
0.0/** ≥65 yrs. IM 
Inactivated 
Influenza Vaccine, 
Quadrivalent (IIV4), 
Standard Dose 
 
Fluarix®  
Quadrivalent 
GlaxoSmithKline 0.5 mL  single dose 
prefilled syringe 
0.0/≤ 0.05 ≥3 yrs. IM 
FluLaval® 
Quadrivalent 
ID Biomedical 
Corporation 
(distributed by GSK) 
0.5 mL single dose 
prefilled syringe 
0.0/≤ 0.3 ≥3 yrs. IM 
5.0 mL multidose vial <25.0/≤ 0.03 ≥3 yrs. 
Fluzone® 
Quadrivalent 
 
Sanofi Pasteur 0.25 mL single dose 
prefilled syringe 
0.0/** 6–35 mos. IM 
0.5 mL single dose 
prefilled syringe 
0.0/**  ≥36 mos. 
0.5 mL single dose vial 0.0/** ≥36 mos. 
5.0 mL multidose vial 25/** ≥6 mos. 
Recombinant Influenza 
Vaccine, 
Trivalent (RIV3) 
FluBlok® Protein Sciences 0.5 mL single dose vial 0.0/0.0 18 – 49 yrs. IM 
Live-attenuated 
Influenza Vaccine, 
Quadrivalent (LAIV4) 
FluMist® 
Quadrivalent 
MedImmune 0.2 mL prefilled 
intranasal sprayer 
0.0/<0.24 (per 0.2 mL) 2–49 yrs. IN 
*50 femtograms  is 5x10-14 grams, of which only a fraction is ovalbumin **Available on request from Sanofi Pasteur, by telephone, (800)822-2463, or e-mail, MIS.Emails@sanofipasteur.com 
Highlighted vaccine products indicate administration route other than IM.  
Adapted from Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the  
Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season.  
The full article is available here.  
  
Pneumococcal Vaccination Recommendations for Adults 
On September 19, the CDC released new pneumococcal vaccination recommendations for the adult 
population.  Adults 65 years of age or older are now recommended to receive a single pneumococcal 
conjugate vaccine (PCV13, Prevnar-13®), followed by the pneumococcal polysaccharide vaccine (PPSV23, 
Pneumovax®23) 6-12 months later.  For adults who previously received a dose of PPSV23 on or after turning 
65 years of age, the PCV13 is recommended to be administered at least 1 year after the PPSV23.  An adult 
annual flu shot visit provides an opportunity to raise awareness of the importance of pneumococcal 
vaccination.  Whenever possible, provide all necessary vaccines at a single visit. The following are links to 
resources regarding pneumococcal vaccination recommendations. 
 
• MMWR article 
• CDC Releases New Recommendations for Pneumococcal Vaccination  
• CDC’s Pneumococcal Vaccination page 
• CDC’s Adult Vaccination page 
• Adult Pneumococcal Vaccine  
 
 
 
 
  
Program Highlights 
SAVE the DATE! 
2015 Immunization Conference 
October 29, 2015 
Community Choice Credit Union/ 
Veteran’s Memorial Auditorium 
Des Moines 
  
 
Adding VFC Flu Vaccine into IRIS Inventory  
As a reminder, all VFC influenza vaccines must be manually added into IRIS inventory.  Flu is the only vaccine 
handled this way, as all other vaccines are accepted through the Manage Transfer option in IRIS.  Direct IRIS 
questions to the IRIS Help Desk at 800-374-3958 Monday through Friday between 8:00 a.m. and 4:30 p.m.  
 
IRIS Password Reset 
The Forgot Password button in IRIS allows users to unlock a disabled account and reset their IRIS password.  In 
order for the Forgot Password functionality to work, users must have an email address on file within their IRIS 
user profile and completed the IRIS security questions.  Admin Users also have the ability to unlock disabled 
user accounts and reset user passwords.  For security purposes, the IRIS Help Desk staff encourages the use of 
the Forgot Password button or referring Standard Users to their Administrative Users.  
 
When a user clicks the Forgot Password Button, the user must enter the correct Org Code, 
Username, and Email Address associated with the account, and then select the ‘Submit’ 
button.  The message, ‘A password reset link has been sent to the email address associated 
with this account’ appears.  The user must check the email address associated with the 
account, where a link to reset the password can be found. The link will be available for 24 
hours.  The link will navigate to the IRIS page where one of the user’s security questions will be 
displayed.  Three attempts are allowed to correctly answer the security question.  The account 
will be locked after the third unsuccessful attempt.  After successfully answering the security 
question, the user must click the ‘Submit’ button.  After correctly answering the security 
question, users will be able to reset their password.  A new password must be entered and 
confirmed. After entering the new password, users must click the ‘Save’ button.  
 
The IRIS website contains a handout with screen shots and step by step instructions.  For 
other questions, please contact the IRIS Help Desk at 800-374-3958.  
 
 
 
VFC Vaccine Distribution 
During the holiday season McKesson will NOT ship vaccine November 25-28 and from December 22, 2014 - 
January 5, 2015.   VFC Program providers should monitor existing vaccine inventory and place vaccine orders 
in advance of shipping black out to ensure adequate vaccine supply.  If you have any questions regarding 
vaccine orders please contact Tina Patterson or Janean Iddings at 1-800-831-6293 ext. 4 and ext. 5, 
respectively. 
 
Vaccine Storage Units  
The Centers for Disease Control and Prevention (CDC), Vaccines for Children (VFC) Program does not allow the 
use of dormitory or bar-style refrigerator/freezer units for storage of federally purchased vaccines under any 
circumstances, including temporary storage.  Performance testing indicates dorm-style units cannot reliably 
maintain appropriate vaccine storage temperatures.  A dorm-style refrigerator is defined as a small 
combination refrigerator/freezer unit that has one external door and an evaporator plate (cooling coil), which 
is usually located inside an icemaker compartment (freezer) within the refrigerator.  
 
IRIS Update 
VFC Highlights 
VFC Vaccine Orders 
When placing VFC vaccine orders, consider the following: 
• IRIS includes a Vaccine Recommended Order Quantity.  This suggested order quantity displays on the 
Create Order screen in IRIS.  The recommended order quantity is calculated based on VFC doses 
administered, doses on hand, and package size.  The recommended order quantity includes at least 15 
days of additional vaccine doses to account for unexpected need.  Adding additional doses of vaccine 
to the vaccine order is not necessary as IRIS automatically calculates additional vaccine inventory.   
• Review doses of combination and single antigen products currently in inventory.  Vaccine loss due to 
expiration is frequently a consequence of over-ordering combination products while an adequate 
supply of single antigens remains in the clinic’s inventory.  This practice is often seen when a 
combination vaccine is available to order after a shortage situation. 
Recommended Order Quantities are based on doses administered during the same time period the 
previous year.  It is important to consider the vaccine products administered during the previous year 
compared to the vaccines the clinic is currently using.  Vaccine orders may need to be adjusted 
regardless of the suggested order quantity displayed in IRIS.   
 
Providers with excessive vaccine loss due to expiration of product may be required to receive additional 
training or pay for vaccines that expire due to ordering issues.  If you have questions regarding vaccine orders, 
contact the VFC Program at 1-800-831-6293 ext. 5. 
 
VFC Vaccine Borrowing 
VFC vaccine borrowing should not routinely occur and should be the exception.  In Iowa, 46% of the vaccine 
reported as borrowed this year was due to administration of a private vaccine dose to a VFC-eligible patient or 
vice versa.  To reduce these types of vaccine management errors, each VFC provider should properly train all 
staff.  Consider labeling vaccine boxes as VFC or Private, placing colored stickers on VFC vaccine boxes, or 
separating privately purchased vaccine from VFC vaccine in a separate unit or on a separate shelf.  
 
All instances of borrowing must be documented on the Vaccine Borrowing Report on the VFC web page.  The 
borrowing report must be completed when privately-purchased vaccine is administered to a VFC-eligible child 
or when VFC vaccine is administered to a privately-insured child.  The provider must: 
• List each vaccine separately 
• Identify whether dose is VFC or private vaccine  
• Document lot number, date borrowed, and why the vaccine was borrowed 
• Include date the vaccine was replaced and lot number  
• Fax report to the Iowa VFC Program at 800-831-6292 
• Maintain a copy of completed form in office records for review during the VFC compliance site visits   
 
If you have questions regarding the VFC Program vaccine inventory requirements and recommendations, 
please contact Tina Patterson at Tina.Patterson@idph.iowa.gov or 1-800-831-6293, ext. 4. 
  
 
 
Q: Our clinic occasionally see patients who report an allergy to eggs, but do not fall within the age 
indications for the Recombinant Influenza Vaccine (RIV).  Should those patients receive regular flu vaccine?  
A:  The recommendation for people with an egg allergy is to receive RIV when available and age 
appropriate.  If RIV is unavailable or not age appropriate, and if only hives is experienced after eating eggs 
or egg-containing foods, Inactivated Influenza Vaccine may be given, but the patient must be observed 
closely for 30 minutes following injection.  If symptoms beyond hives are experienced, the influenza vaccine 
should be administered by a physician with experience in recognizing and managing severe allergic 
conditions.  A 30-minute observation for reactions after vaccination should occur for these patients as well. 
 
Q:  In years past, when a child did not receive at least 2 doses of seasonal influenza vaccine in a single 
season, it was recommended they receive two doses the next season.  This year’s recommendation is 
slightly different and specifies if a child received just one dose of last season’s flu vaccine, they will only 
need one dose this season. Is this accurate? 
A: Yes, the strains in this season’s flu vaccine are exactly the same as those covered in last season’s flu 
vaccine.  Only one dose is necessary this season for children 6 months through 8 years of age who received 
a dose last season.  For children who received a dose of last season’s flu vaccine, getting one dose this 
season serves to boost the immunity gained last season.  Even if a child received a trivalent flu vaccine last 
season and a quadrivalent flu vaccine this season, only one additional dose of vaccine is necessary. 
  
Q:  What is the recommended interval for receiving influenza vaccine after an allergy injection? 
A: Influenza vaccine may be administered at any time before or after administration of an allergy injection.  
 
Q:  The Prevnar13 vaccine only has a month and year listed for the expiration date.  Do we need to discard 
unused doses at the beginning or end of that month? 
A: When an expiration date on a vaccine only has a month and year listed, the vaccine may be used 
through the last day of that month.  For example, if the expiration date is November 2014, the last day you 
may administer a dose of that vaccine is November 30, 2014.  
 
 
 
 
 
Seasonal Influenza Vaccine Resources 
• Live, Intranasal Influenza VIS 
• Inactivated Influenza VIS  
• CDC 2014-2015 Seasonal Influenza Information 
• Prevention & Control of Seasonal Influenza Recommendations from the ACIP, 2014-2015 Influenza 
Season 
 
Iowa Department of Public Health, Immunization Bureau Email Lists  
The Iowa Immunization Program has several email list serves available to help health care providers receive 
important and timely immunization related information.  Providers can send a blank email to the addresses 
below to receive updates directly in their inbox.  
• VFC List: join-VFC@lists.ia.gov 
• Immunization Program List: join-IMMUNIZATION@lists.ia.gov  
• IRIS List: join-IRISUSERS@lists.ia.gov  
Question Corner 
Resources 
Upcoming IRIS Q&A Webinars 
• Thursday 11/20/14 at 10 a.m.  
• Wednesday 12/17/14 at 2:00 p.m.  
• Thursday 1/22/15 at 10 am.  
• Wednesday 2/18/15 at 2:00 p.m.  
Registration links can be found on the IRIS website.   
